SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-22-000184
Filing Date
2022-05-13
Accepted
2022-05-13 13:19:20
Documents
29
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl0513form10q.htm   iXBRL 10-Q 181100
2 EXHIBIT 31.1 cncl0513form10qexh31_1.htm EX-31.1 8094
3 EXHIBIT 31.2 cncl0513form10qexh31_2.htm EX-31.2 8086
4 EXHIBIT 32.1 cncl0513form10qexh32_1.htm EX-32.1 3865
  Complete submission text file 0001554795-22-000184.txt   1001392

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20220331.xsd EX-101.SCH 8999
6 XBRL CALCULATION FILE cncl-20220331_cal.xml EX-101.CAL 17446
7 XBRL DEFINITION FILE cncl-20220331_def.xml EX-101.DEF 10314
8 XBRL LABEL FILE cncl-20220331_lab.xml EX-101.LAB 94004
9 XBRL PRESENTATION FILE cncl-20220331_pre.xml EX-101.PRE 67874
23 EXTRACTED XBRL INSTANCE DOCUMENT cncl0513form10q_htm.xml XML 45333
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 22921546
SIC: 6770 Blank Checks